World Cancer Day

The role of ZEISS in fighting cancer

Read more

ZEISS Group

Solutions that shape technological progress

Diagnose & Treat

Researching into Micro- and Nanostructures

Assure Industrial Quality Excellence

Enabling Chip Manufacturers

Photograph & Film

Skater boy practicing at the skate park

Create Virtual Worlds

Observe & Experience

Discover ZEISS

Fascinating insights into the world of optics

AI for Humanity

Interview with Lila Tretikov, Deputy CTO at Microsoft

go to interview

Surgical precision at the edge of science

Interview with pioneer neurosurgeon Prof. Robert Spetzler

go to interview

The paradox of exponential innovation

Interview with Martin van den Brink, President and CTO at ASML

go to interview

ZEISS Updates

The following page serves ZEISS employees as an alternative source of information should the IT network, TEAM ZEISS and other communication channels ever fail and not be available again at short notice.

learn more

News & Events

News from the ZEISS Group

10 February 2023

Carl Zeiss Meditec achieves further revenue growth in Q1 2022/23

Press Release

Carl Zeiss Meditec AG Statement Q1 FY 2022/23

Carl Zeiss Meditec generated revenue of €470.3m in the first quarter of fiscal year 2022/23 (prior year: €410.2m), corresponding to growth of +14.6% (adjusted for currency effects: +12.1%). Orders on hand remained high at over €600m. Earnings before interest and taxes (EBIT) decreased to around €60.3m (prior year: €74.4m). The EBIT margin was 12.8% (prior year: 18.1%).

14 December 2022

Another very successful year for the ZEISS Group

Press Release

Another very successful year for the ZEISS Group

The ZEISS Group achieved significant growth across all segments despite challenging geopolitical and economic conditions. Revenue rose by 16% to 8.8 billion euros, surpassing over 8 billion euros for the first time (prior year: 7.5 billion euros) in fiscal year 2021/22 (end of reporting period: 30 September 2022).

9 December 2022

Carl Zeiss Meditec remains on growth course in fiscal year 2021/22

Press Release

Carl Zeiss Meditec remains on growth course in fiscal year 2021/22

Carl Zeiss Meditec generated revenue of around €1,903m in fiscal year 2021/22 (prior year: €1,647m), corresponding to growth of +15.5% (adjusted for currency effects: +13.3%). Orders received increased even more significantly to around €2,251m (+30.1%, adjusted for currency effects: +27.7%).